Woodbury, MN, United States of America

Xiaohong Zhou

This inventor holds 73 USPTO granted patents and 25 published patent applications and 22 EPO patents, primarily in Cardiac Pacing (CPC class A61N). Top assignee: Medtronic, Inc.. Active years: 2005-2026.

USPTO Granted Patents = 73 

% Patents Active = 83.6

 

Average Co-Inventor Count = 2.8

ph-index = 19

Forward Citations = 2,310(Granted Patents)

Forward Citations (Not Self Cited) = 2,160(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Plymouth, MN (US) (2005 - 2017)
  • Woodbury, MN (US) (2011 - 2024)

Company Filing History:


Years Active: 2005-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Cardiac Pacing
His-Purkinje System
Bundle Branch Pacing
Implantable Medical Devices
Acute Cardiac Monitoring
Vagal Stimulation
Electromechanical Dissociation
Nerve Signal Differentiation
Acoustic Monitoring
Pacing Capture Classification
Multi-Parameter Prediction
Cardiac Function Monitoring
73 patents (USPTO):Explore Patents

Title: Xiaohong Zhou: Innovator in Predictive Healthcare and Cardiac Device Technology

Introduction:

Xiaohong Zhou, a prolific inventor based in Woodbury, MN, has made significant contributions to the field of healthcare technology, specifically in the areas of predictive cardiac episode detection and advancements in cardiac device systems. With an impressive portfolio of 58 patents, Zhou continues to drive innovation in the medical field, improving patient care and enhancing the effectiveness of medical devices.

Latest Patents:

Zhou's recent inventions demonstrate his expertise in multi-parameter prediction of acute cardiac episodes and attacks. In one patent, he introduces a medical device system that utilizes processing circuitry to predict acute cardiac events, such as ventricular tachyarrhythmia. By analyzing a range of patient parameters and determining difference metrics and scores, the system can generate alerts and deliver therapies to prevent such events. This groundbreaking technology has the potential to save lives and improve the quality of care for patients with cardiac conditions.

Another notable patent by Zhou focuses on His-Purkinje system capture detection. This invention incorporates the sensing of cardiac electrical signals to determine maximum peak amplitude and peak time intervals. By analyzing these parameters, the device can determine the capture type of a pacing pulse, providing valuable insights into the efficiency and efficacy of cardiac therapies.

Career Highlights:

Throughout his career, Zhou has made significant contributions in the healthcare industry. His work with leading medical technology company Medtronic, Inc (previously known as MINNESOTA MINING AND MANUFACTURING COMPANY) has been instrumental in advancing cardiac care. Zhou's expertise and contributions have helped shape the future of medical devices and technology, improving patient outcomes and enhancing the lives of individuals with cardiac conditions.

Collaborations:

In his professional journey, Zhou has worked alongside esteemed colleagues such as John E Burnes and William T Donofrio. These collaborations have fostered an environment of innovation and knowledge sharing, leading to breakthroughs in the medical field. The collective expertise of these inventors has facilitated advancements in cardiac device technology and predictive healthcare, further solidifying Zhou's reputation as a trailblazer in his field.

Conclusion:

Xiaohong Zhou's extensive patent portfolio and contributions in the field of predictive healthcare and cardiac device technology highlight his commitment to improving patient care. With his innovations at the intersection of medical devices and data analysis, Zhou's work has the potential to transform the landscape of cardiac care and enhance the lives of patients worldwide. As he continues to push boundaries and demonstrate his expertise, Zhou's impact on the medical field will undoubtedly continue to grow, empowering both clinicians and patients in combating cardiac conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…